Drug
Immunoglobulin G
Immunoglobulin G: highest development phase Phase 3, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Immunoglobulin G (Ig NextGen 16%) NCT00680446 | Phase 3 | Primary Immune Deficiency |
Latest
No recent events.
Follow Immunoglobulin G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.